Back to search

National and Kapodistrian University of Athens

Επίδραση της θεραπείας με διφωσφονικά στον οστικό μεταβολισμό σε παιδιά με ατελή αστεογένεση

Abstract

dc:description

Osteogenesis imperfecta (OI) is a phenotypically and molecularly heterogenous group of inherited connective tissue disorders that share similar skeletal abnormalities causing bone fragility and deformity, leading to growth deficiency.Bisphosphonates are potent antiresorptive agents that inhibit osteoclast function. We aimed to assess in children with OI the effects of treatment with bisphosphonates on the number of fractures, bone mass density (BMD), markers of bone metabolism and receptor activator of nuclear factor-κB (sRANKL) and osteoprotegerin (OPG) levels.Ten children with a clinical diagnosis of OI, median age 8.12 years, were included in the study. The patients received pamidronate infusions on two consecutive days, administered at age-dependent intervals of eight to sixteen weeks or zoledronic acid once every six months, for a period of twelve months. Clinical changes were evaluated regularly during treatment and changes of BMD were assessed after twelve months of treatment. Serum levels of biochemical markers (Ca, iCa, P, Cr, PTH, 25-OH-D), markers of bone formation (total ALP, bALP), markers of bone resorption (CTX, uCa, PYD, DPD) and sRANKL and OPG were measured before and 48 hours after each bisphosphonate course.Bisphosphonate administration was safe and well tolerated by the patients. Patients reported increase in appetite, decrease in sweating, relief of chronic pain and fatigue and increase in functional capacity.Anthropometric measurements did not change. New fractures did not occur, except in one patient.During bisphosphonate treatment vertebral shape and size increased and BMD increased significantly.Both markers of bone resorption and bone formation decreased, while serum levels of sRANKL and OPG remained unchanged.In conclusion, in children with OI administration of bisphosphonates for a period of twelve months had a positive impact on skeletal health.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papaphylactou, Maria
  • Παπαφυλακτού, Μαρία

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43742

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papaphylactou, Maria; Παπαφυλακτού, Μαρία. Επίδραση της θεραπείας με διφωσφονικά στον οστικό μεταβολισμό σε παιδιά με ατελή αστεογένεση. National and Kapodistrian University of Athens, 2018. http://hdl.handle.net/10442/hedi/43742